These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 8427775

  • 1. Humoral mediation for cachexia in tumour-bearing rats.
    Tessitore L, Costelli P, Baccino FM.
    Br J Cancer; 1993 Jan; 67(1):15-23. PubMed ID: 8427775
    [Abstract] [Full Text] [Related]

  • 2. Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals.
    Tessitore L, Costelli P, Bonetti G, Baccino FM.
    Arch Biochem Biophys; 1993 Oct; 306(1):52-8. PubMed ID: 8215420
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).
    Dessì S, Batetta B, Spano O, Bagby GJ, Tessitore L, Costelli P, Baccino FM, Pani P, Argilès JM.
    Br J Cancer; 1995 Nov; 72(5):1138-43. PubMed ID: 7577459
    [Abstract] [Full Text] [Related]

  • 5. Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model.
    Costelli P, Carbó N, Tessitore L, Bagby GJ, Lopez-Soriano FJ, Argilés JM, Baccino FM.
    J Clin Invest; 1993 Dec; 92(6):2783-9. PubMed ID: 8254032
    [Abstract] [Full Text] [Related]

  • 6. Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats.
    Llovera M, García-Martínez C, Agell N, Marzábal M, López-Soriano FJ, Argilés JM.
    FEBS Lett; 1994 Feb 07; 338(3):311-8. PubMed ID: 8307200
    [Abstract] [Full Text] [Related]

  • 7. Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia.
    Tessitore L, Bonelli G, Baccino FM.
    Biochem J; 1987 Jan 01; 241(1):153-9. PubMed ID: 3566707
    [Abstract] [Full Text] [Related]

  • 8. Lack of effect of eicosapentaenoic acid in preventing cancer cachexia and inhibiting tumor growth.
    Costelli P, Llovera M, López-Soriano J, Carbó N, Tessitore L, López-Soriano FJ, Baccino FM, Argilés JM.
    Cancer Lett; 1995 Oct 20; 97(1):25-32. PubMed ID: 7585474
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.
    Costelli P, García-Martínez C, Llovera M, Carbó N, López-Soriano FJ, Agell N, Tessitore L, Baccino FM, Argilés JM.
    J Clin Invest; 1995 May 20; 95(5):2367-72. PubMed ID: 7738199
    [Abstract] [Full Text] [Related]

  • 11. Amino acid uptake in skeletal muscle of rats bearing the Yoshida AH-130 ascites hepatoma.
    García-Martínez C, López-Soriano FJ, Argilés JM.
    Mol Cell Biochem; 1995 Jul 05; 148(1):17-23. PubMed ID: 7476929
    [Abstract] [Full Text] [Related]

  • 12. Alterations of lipid and cholesterol metabolism in cachectic tumor-bearing rats are prevented by insulin.
    Costelli P, Tessitore L, Batetta B, Mulas MF, Spano O, Pani P, Baccino FM, Dessì S.
    J Nutr; 1999 Mar 05; 129(3):700-6. PubMed ID: 10082777
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-1 receptor antagonist (IL-1ra) is unable to reverse cachexia in rats bearing an ascites hepatoma (Yoshida AH-130).
    Costelli P, Llovera M, Carbó N, García-Martínez C, López-Sorianoq FJ, Argilés JM.
    Cancer Lett; 1995 Aug 16; 95(1-2):33-8. PubMed ID: 7656241
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats.
    Carbó N, López-Soriano J, Costelli P, Busquets S, Alvarez B, Baccino FM, Quinn LS, López-Soriano FJ, Argilés JM.
    Br J Cancer; 2000 Aug 16; 83(4):526-31. PubMed ID: 10945502
    [Abstract] [Full Text] [Related]

  • 15. Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis.
    Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ, Argiles JM.
    Int J Cancer; 1995 Mar 29; 61(1):138-41. PubMed ID: 7705927
    [Abstract] [Full Text] [Related]

  • 16. Protein turnover states of tumour cells and host tissues in an experimental model.
    Baccino FM, Tessitore L, Bonelli G, Isidoro C.
    Biomed Biochim Acta; 1986 Mar 29; 45(11-12):1585-90. PubMed ID: 3579877
    [Abstract] [Full Text] [Related]

  • 17. Enhanced leucine oxidation in rats bearing an ascites hepatoma (Yoshida AH-130) and its reversal by clenbuterol.
    Costelli P, Llovera M, García-Martínez C, Carbó N, López-Soriano FJ, Argilés JM.
    Cancer Lett; 1995 May 04; 91(1):73-8. PubMed ID: 7750097
    [Abstract] [Full Text] [Related]

  • 18. Muscle hypercatabolism during cancer cachexia is not reversed by the glucocorticoid receptor antagonist RU38486.
    Llovera M, García-Martínez C, Costelli P, Agell N, Carbó N, López-Soriano FJ, Argilés JM.
    Cancer Lett; 1996 Jan 19; 99(1):7-14. PubMed ID: 8564931
    [Abstract] [Full Text] [Related]

  • 19. Lack of effect of the cytokine suppressive agent FR167653 on tumour growth and cachexia in rats bearing the Yoshida AH-130 ascites hepatoma.
    Busquets S, Alvarez B, van Royen M, Carbó N, López-Soriano FJ, Argilés JM.
    Cancer Lett; 2000 Aug 31; 157(1):99-103. PubMed ID: 10893448
    [Abstract] [Full Text] [Related]

  • 20. Changes in blood metabolic parameters during the development of Walker-256 tumour-induced cachexia in rats are not caused by decreased food intake.
    Cassolla P, Moreira CC, Liboni TF, Zaia CT, Borba-Murad GR, Bazotte RB, de Souza HM.
    Cell Biochem Funct; 2012 Jun 31; 30(4):265-70. PubMed ID: 22179849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.